Veracyte, Inc. Announces New Data Supporting Clinical Validity of Afirma® Gene Expression Classifier
October 29, 2014Veracyte shares data at the 84th Annual Meeting of the American Thyroid Assocation supporting the company's Afirma Gene Expression Classifier (GEC), used to manage thyroid nodules in cancer patients.
More »
Celator® Pharmaceuticals Announces Phase 3 Clinical Study of CPX-351 Achieved Target Enrollment in High Risk (Secondary) Acute Myeloid Leukemia
October 27, 2014Celator Pharmaceuticals reaches its target enrollment of 300 patients in its Phase 3 study of CPX-351 Liposome for Injection in patients with untreated high-risk (secondary) acute myeloid leukemia and remains on track to report initial data in Q2 2015.
More »
Zyga Technology Receives CE Mark Approval for Glyder Facet Restoration Device
October 27, 2014Zyga Technology receives CE Mark approval of the Glyder® Facet Restoration Device, a non-fusion minimally invasive solution for patients with low back pain caused by facet joint degeneration.
More »